SANDOZ INC FDA Approval ANDA 216890

ANDA 216890

SANDOZ INC

FDA Drug Application

Application #216890

Application Sponsors

ANDA 216890SANDOZ INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL0.125MG0TRIAZOLAMTRIAZOLAM
002TABLET;ORAL0.25MG0TRIAZOLAMTRIAZOLAM

FDA Submissions

UNKNOWN; ORIG1AP2022-11-08STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

SANDOZ INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216890
            [companyName] => SANDOZ INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRIAZOLAM","activeIngredients":"TRIAZOLAM","strength":"0.125MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TRIAZOLAM","activeIngredients":"TRIAZOLAM","strength":"0.25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/08\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-11-08
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.